1.Computed tomographic angiography: diagnosis and pre-therapy evaluation of intracranial aneurysms
Journal of Practical Medicine 2005;512(5):66-69
44 patients (between 29 and 77 years old), admitted to Royal Perth Hospital, Weskin state of Australia with suspected symptoms of intracranial aneurysms underwent assessment of using both computed tomographic angiography (CTA) and Digital Subtraction Angiography (DSA). The results: 36 patients had 43 detectable intracranial aneurysm, 26 patients had 1 aneurysm, 5 patients had 2 aneurysms, 1 patient had 3 aneurysms and 8 patients had no detectable aneurysms in both CTA and DSA. CTA was a noninvasive imaging technique with high sensitivity, specificity and accuracy in diagnosis of intracranial aneurysms
Intracranial Aneurysm
;
Diagnosis
2.Safety of epinephrine for anaphylaxis in the emergency setting
Wood P JOSEPH ; Traub J STEPHEN ; Lipinski CHRISTOPHER
World Journal of Emergency Medicine 2013;4(4):245-251
BACKGROUND: While epinephrine is the recommended first-line therapy for the reversal of anaphylaxis symptoms, inappropriate use persists because of misunderstandings about proper dosing and administration or misconceptions about its safety. The objective of this review was to evaluate the safety of epinephrine for patients with anaphylaxis, including other emergent conditions, treated in emergency care settings. METHODS: A MEDLINE search using PubMed was conducted to identify articles that discuss the dosing, administration, and safety of epinephrine in the emergency setting for anaphylaxis and other conditions. RESULTS: Epinephrine is safe for anaphylaxis when given at the correct dose by intramuscular injection. The majority of dosing errors and cardiovascular adverse reactions occur when epinephrine is given intravenously or incorrectly dosed. CONCLUSION: Epinephrine by intramuscular injection is a safe therapy for anaphylaxis but training may still be necessary in emergency care settings to minimize drug dosing and administration errors and to allay concerns about its safety.
3.Analysis of surgeries performed after hysteroscopic sterilization as tabulated from 3,803 Essure patient experiences.
E Scott SILLS ; Xiang LI ; Samuel H WOOD ; Christopher A JONES
Obstetrics & Gynecology Science 2017;60(3):296-302
OBJECTIVE: Although previous research has suggested that risk for reoperation among hysteroscopic sterilization (HS) patients is more than ten times higher than for patients undergoing standard laparoscopic tubal ligation, little has been reported about these subsequent procedures. METHODS: This descriptive cohort study used a confidential online questionnaire to gather data from women (n=3,803) who volunteered information on HS followed by device removal surgery performed due to new symptoms developing after Essure placement. RESULTS: In this sample, mean age was 35.6 years and women undergoing hysterectomy after HS comprised 64.9% (n=2,468). Median interval between HS and hysterectomy was 3.7 (interquartile range, 3.9) years and mean age at hysterectomy was 36.3 years. Some patients (n=1,035) sought removal of HS devices and fallopian tubes only, while other miscellaneous gynecological procedures were also occasionally performed for Essure-associated symptoms. When data from all patients who had any post-Essure surgery besides hysterectomy were aggregated (e.g., device removal +“other” cases, n=1,335) and compared to those cases undergoing hysterectomy, mean age was significantly lower than for the hysterectomy group (34.4 vs. 36.3 years, respectively; P<0.01); uterus-conserving surgeries were also typically performed significantly earlier than hysterectomy (P<0.01). CONCLUSION: This investigation is the first to characterize specific gynecological operations after Essure, and suggests that the predominant surgical answer to HS complaints is hysterectomy for many women. Dissatisfaction with HS may represent an important indication for hysterectomy and additional study is needed to quantify this phenomenon.
Cohort Studies
;
Contraception
;
Device Removal
;
Fallopian Tubes
;
Female
;
Humans
;
Hysterectomy
;
Reoperation
;
Sterilization*
;
Sterilization, Tubal
4.Contraceptive failure after hysteroscopic sterilization: Analysis of clinical and demographic data from 103 unplanned pregnancies.
E Scott SILLS ; Xiang LI ; Christopher A JONES ; Samuel H WOOD
Obstetrics & Gynecology Science 2015;58(6):487-493
OBJECTIVE: This investigation examined data on unplanned pregnancies following hysteroscopic sterilization (HS). METHODS: A confidential questionnaire was used to collect data from women with medically confirmed pregnancy (n=103) registered after undergoing HS. RESULTS: Mean (+/-SD) patient age and body mass index (BMI) were 29.5+/-4.6 years and 27.7+/-6.1 kg/m2, respectively. Peak pregnancy incidence was reported at 10 months after HS, although <3% of unplanned pregnancies occurred within the first three months following HS. Mean (+/-SD) interval between HS and pregnancy was 19.6+/-14.9 (range, 2 to 84) months. Patients age > or =30 years and BMI <25 reported conception after HS somewhat sooner than younger patients, although the differences in time to pregnancy were not significant (P=0.24 and 0.09, respectively). The recommended post-HS hysterosalpingogram (to confirm proper placement and bilateral tubal occlusion) was obtained by 66% (68/103) of respondents. CONCLUSION: This report is the first to provide patient-derived data on contraceptive failures after HS. While adherence to backup contraception 3 months after HS can be poor, many unintended pregnancies with HS occur long after the interval when alternate contraceptive is required. Many patients who obtain HS appear to ignore the manufacturer's guidance regarding the post-procedure hysterosalpingogram to confirm proper device placement, although limited insurance coverage likely contributes to this problem. The greatest number of unplanned pregnancies occurred 10 months after HS, but some unplanned pregnancies were reported up to 7 years later. Age, BMI, or surgical history are unlikely to predict contraceptive failure with HS. Further follow-up studies are planned to capture additional data on this issue.
Body Mass Index
;
Contraception
;
Surveys and Questionnaires
;
Female
;
Fertilization
;
Follow-Up Studies
;
Humans
;
Incidence
;
Insurance Coverage
;
Pregnancy
;
Pregnancy, Unplanned*
;
Sterilization*
;
Time-to-Pregnancy
5.Endometrial fluid associated with Essure implants placed before in vitro fertilization: Considerations for patient counseling and surgical management.
E Scott SILLS ; David J WALSH ; Christopher A JONES ; Samuel H WOOD
Clinical and Experimental Reproductive Medicine 2015;42(3):126-129
Essure (Bayer) received approval from the U.S. Food and Drugs Administration as a permanent non-hormonal contraceptive implant in November 2002. While the use of Essure in the management of hydrosalpinx prior to in vitro fertilization (IVF) remains off-label, it has been used specifically for this purpose since at least 2007. Although most published reports on Essure placement before IVF have been reassuring, clinical experience remains limited, and no randomized studies have demonstrated the safety or efficacy of Essure in this context. In fact, no published guidelines deal with patient selection or counseling regarding the Essure procedure specifically in the context of IVF. Although Essure is an irreversible birth control option, some patients request the surgical removal of the implants for various reasons. While these patients could eventually undergo hysterectomy, at present no standardized technique exists for simple Essure removal with conservation of the uterus. This article emphasizes new aspects of the Essure procedure, as we describe the first known association between the placement of Essure implants and the subsequent development of fluid within the uterine cavity, which resolved after the surgical removal of both devices.
Contraception
;
Counseling*
;
Fertilization in Vitro*
;
Humans
;
Hysterectomy
;
Laparoscopy
;
Patient Selection
;
Uterus
6.The Effects of Sociodemographic Factors on Psychiatric Diagnosis.
Mal Rye CHOI ; Hun Jeong EUN ; Tai P YOO ; Youngmi YUN ; Christopher WOOD ; Michael KASE ; Jong Il PARK ; Jong Chul YANG
Psychiatry Investigation 2012;9(3):199-208
OBJECTIVE: Several studies have reported that ethnic differences influence psychiatric diagnoses. Some previous studies reported that African Americans and Hispanics are diagnosed with schizophrenia spectrum disorders more frequently than Caucasians, and that Caucasians are more likely to be diagnosed with affective disorders than other ethnic groups. We sought to identify associations between sociodemographic factors and psychiatric diagnosis. METHODS: We retrospectively examined the medical records of all psychiatric inpatients (ages over 18 years) treated at Kern county mental hospital (n=2,051) between July 2003 and March 2007 for demographic, clinical information, and discharge diagnoses. RESULTS: African American and Hispanic males were more frequently diagnosed with schizophrenia spectrum disorders than Caucasians, whereas Caucasian females were more frequently diagnosed with affective disorders than females in the other ethnic groups, suggesting that patient ethnicity and gender may influence clinical diagnoses. Demographic variables, that is, a lower education, failure of marriage, homelessness, and low quality insurance, were found to be significantly associated with a diagnosis of schizophrenia spectrum disorders after adjusting for clinical variables. And, the presence of a family psychiatric history, failure of marriage, not-homelessness, and quality insurance were found to be associated with a diagnosis of affective disorders. CONCLUSION: Our results show that these demographic factors, including ethnicity, have effects on diagnoses in psychiatric inpatients. Furthermore, these variables may help prediction of psychiatric diagnoses.
African Americans
;
Demography
;
Ethnic Groups
;
Female
;
Hispanic Americans
;
Homeless Persons
;
Hospitals, Psychiatric
;
Humans
;
Inpatients
;
Insurance
;
Male
;
Marriage
;
Medical Records
;
Mental Disorders
;
Mood Disorders
;
Retrospective Studies
;
Schizophrenia